Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHT-Gel for Hypogonadism in Older Men
NCT00163566Phase 2Completed
- Sponsor
- ASCEND Therapeutics US, LLC
- Start
- Oct 2004
- Primary completion
- Sep 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dihydrotestosterone in Hypogonadism (3 arms), sponsored by ASCEND Therapeutics US, LLC. Primary endpoint: Change in Body Composition. Started Oct 2004; status: completed.
02
Drugs
dihydrotestosterone
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT00163566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00163566.